University of Massachusetts Amherst

ScholarWorks@UMass Amherst
Chemical Engineering Faculty Publication Series

Chemical Engineering

2015

Smooth Muscle Stiffness Sensitivity is Driven by
Soluble and Insoluble ECM Chemistry
William G. Herrick
University of Massachusetts - Amherst

Shruti Rattan
University of Massachusetts Amherst

Thuy V. Nguyen
University of Massachusetts Amherst

Michael S. Grunwald
University of Massachusetts Amherst

Christopher W. Barney
Purdue University
See next page for additional authors

Follow this and additional works at: https://scholarworks.umass.edu/che_faculty_pubs
Part of the Biochemical and Biomolecular Engineering Commons
Recommended Citation
Herrick, William G.; Rattan, Shruti; Nguyen, Thuy V.; Grunwald, Michael S.; Barney, Christopher W.; Crosby, Alfred J.; and Peyton,
Shelly, "Smooth Muscle Stiffness Sensitivity is Driven by Soluble and Insoluble ECM Chemistry" (2015). Cellular and Molecular
Bioengineering. 845.
https://doi.org/10.1007/s12195-015-0397-4

This Article is brought to you for free and open access by the Chemical Engineering at ScholarWorks@UMass Amherst. It has been accepted for
inclusion in Chemical Engineering Faculty Publication Series by an authorized administrator of ScholarWorks@UMass Amherst. For more
information, please contact scholarworks@library.umass.edu.

Authors

William G. Herrick, Shruti Rattan, Thuy V. Nguyen, Michael S. Grunwald, Christopher W. Barney, Alfred J.
Crosby, and Shelly Peyton

This article is available at ScholarWorks@UMass Amherst: https://scholarworks.umass.edu/che_faculty_pubs/845

Smooth Muscle Stiffness Sensitivity is Driven by Soluble and Insoluble
ECM Chemistry
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Department of Chemical Engineering, University of Massachusetts, 686 N. Pleasant Street, 159 Goessmann Laboratory,
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Abstract—Smooth muscle cell (SMC) invasion into plaques
and subsequent proliferation is a major factor in the
progression of atherosclerosis. During disease progression,
SMCs experience major changes in their microenvironment,
such as what integrin-binding sites are exposed, the portfolio
of soluble factors available, and the elasticity and modulus of
the surrounding vessel wall. We have developed a hydrogel
biomaterial platform to examine the combined effect of these
changes on SMC phenotype. We were particularly interested
in how the chemical microenvironment affected the ability of
SMCs to sense and respond to modulus. To our surprise, we
observed that integrin binding and soluble factors are major
drivers of several critical SMC behaviors, such as motility,
proliferation, invasion, and differentiation marker expression, and these factors modulated the effect of stiffness on
proliferation and migration. Overall, modulus only modestly
affected behaviors other than proliferation, relative to
integrin binding and soluble factors. Surprisingly, pathological behaviors (proliferation, motility) are not inversely
related to SMC marker expression, in direct conﬂict with
previous studies on substrates coupled with single extracellular matrix (ECM) proteins. A high-throughput bead-based
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ELISA approach and inhibitor studies revealed that differentiation marker expression is mediated chieﬂy via focal
adhesion kinase (FAK) signaling, and we propose that
integrin binding and FAK drive the transition from a
migratory to a proliferative phenotype. We emphasize the
importance of increasing the complexity of in vitro testing
platforms to capture these subtleties in cell phenotypes and
signaling, in order to better recapitulate important features of
in vivo disease and elucidate potential context-dependent
therapeutic targets.

Keywords—Extracellular matrix, Mechanobiology,
Poly(ethylene glycol), Hydrogel, Atherosclerosis.

INTRODUCTION
SMCs play an important role in the pathogenesis of
atherosclerosis, the primary cause of heart disease and
stroke. If stimulated during disease, these otherwise
quiescent, immobilized, and contractile cells will degrade their surrounding ECM and invade developing
plaques, where they rapidly proliferate and secrete

ECM proteins, initiating a positive feedback loop, and
contributing to arterial stiﬀening.
Of major interest to this ﬁeld are the eﬀects of substrate compliance on cellular behaviors relevant to the
disease, such as proliferation and migration. These
characteristics are most commonly investigated with
biocompatible hydrogels that have control over both
modulus and cell adhesion.17,28,34,42,47 With these in
vitro model systems, some common trends have
emerged. Typically, cell proliferation is positively correlated with substrate compliance, both for SMCs 33,35
and other cells.15 ECM proteins and other adhesive ligands, in concert with substrate elasticity, also regulate
proliferation and migration of SMCs13,14,28,34 and their
sensitivity to soluble factors.42,44,49 Despite their simplistic design, these in vitro systems have revealed substantial and important information about the effects of
environmental factors on cellular phenotype.
Though the majority of literature in this ﬁeld has
consensus, there is some conﬂict and ambiguity among
in vitro studies, and, separately, many in vitro studies
do not recapitulate, or in some cases, directly conﬂict
with in vivo studies.9,12,20,22,39 As one example, SMC
proliferation and motility are typically inversely related to expression of protein markers in vitro and in vivo,
but conﬂicting reports9,12,20 raise serious questions regarding the true diversity of SMC phenotypes and the
interrelation between the extracellular environment,
phenotype, and pathological behaviors.
Broadly, we hypothesize that these literature disagreements are due to signiﬁcant diﬀerences between
human biology, in vitro models, and in vivo animal
models. The in vivo arterial microenvironment is
complex and heterogeneous, and we hypothesize that a
lack of recapitulation of this ECM complexity may be
partially to blame for conﬂicts between in vitro and
in vivo ﬁndings. Further, SMCs themselves reside on a
spectrum of phenotypes, yet only two phenotypes are
typically described: in a healthy, intact arterial media,
SMCs are differentiated and ‘contractile’, whereas
proliferative SMCs in an atherosclerotic lesion are the
dedifferentiated, ‘synthetic’ phenotype. In response, we
investigated SMC phenotypic diversity with a polymeric biomaterial system designed to capture the intersection of physical, chemical, and mechanical
signals in the microenvironment. We used poly
(ethylene glycol) dimethacrylate-phosphorylcholine
(PEG-PC) hydrogels18,32 that we recently developed as
a tunable biomaterial substrate, and coated them with
mixtures of integrin-binding ECM proteins representative of ECM evolution in a vessel during plaque
formation. We forced SMCs into the contractile phenotype chemically, and then quantiﬁed their plasticity
toward the synthetic phenotype as modulated by substrate stiffness, integrin binding, and soluble factors.

With this subtly more complex system, we were better
able to see this spectrum of SMC phenotypes, which
we found was driven by FAK, phosphatidylinositol 3kinase (PI3K), and Akt signaling. This study represents an early step towards closer replication of the
in vivo microenvironment, and we hope our work will
inspire others to carefully consider the effects of numerous relevant stimuli on SMC behavior, with any
tunable platform.

MATERIALS AND METHODS
Cell Culture
All reagents were from Life Technologies (Carlsbad,
CA), unless otherwise noted. Human aortic smooth muscle cells (SMCs) from passages 2 through 8 were cultured in
Medium 231 supplemented with smooth muscle growth
supplement (SMGS) and 1% penicillin–streptomycin
(P/S). For experiments, medium was changed to DMEM
with 10% FBS. Cells were synched into the contractile
phenotype with serum starvation for 48 h, and stimulation
with 2.5 ng/mL recombinant human TGFb1 (R&D Systems, Minneapolis, MN) for an additional 48 h.
PEG-PC Hydrogel Polymerization and Contact
Mechanics Measurements
PEG-PC polymer hydrogels were prepared on
methacrylate-functionalized 15 mm coverslips (Thermo Fisher Scientiﬁc, Waltham, MA) as previously
described.18,32 To quantify the elastic moduli of the
hydrogels directly on the coverslips, a piezo-controlled
linear actuator (Burleigh Inchworm Nanopositioner)
was used to bring a polystyrene-coated steel cylindrical
probe (cross-sectional radius ~0.75 mm) into contact
with a sample. Upon contact and reproach, the relative
displacement, d, and resulting force, P, were measured
with a custom-designed load cell (Fig. 1a). In addition,
the contact radius, a, established between the probe
and the gel was conﬁrmed to equal the radius of the
probe with a Zeiss Axiovert 200 M microscope (Carl
Zeiss, Oberkochen, Germany). Tests were conducted
at a crosshead speed of 0.5 lm/s and the total displacement for each test was ﬁxed at 30 lm. Linearity
of the force–displacement curve was also conﬁrmed for
a crosshead speed of 0.1 lm/s (Suppl. Fig. 1).
To quantify the elastic modulus, the compliance,
@d, was determined from the linear
C ¼ @P
force–displacement curves (Fig. 1a), and the modulus, E, determined by40:
(
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FIGURE 1. PEG-PC hydrogels that mimic the in vivo microenvironment of SMCs. (a) PEG-PC hydrogel elastic modulus on glass
coverslips was measured with contact mechanics by bringing a cylindrical probe into contact with the gel surface and measuring
the force, P, vs. displacement, d, with a displacement rate of 0.5 lm/s. Data is plotted with compressive force and displacement
values being positive (b) The effective modulus, E *, was measured over a range of [PEGDMA] concentrations from a minimum of
three samples per condition, and used to calculate a Young’s modulus, E, with an estimated Poisson’s ratio of 0.5. (c) PEG-PC
mechanical data plotted as a function of crosslinker (PEGDMA) concentration. (d) Two different compositions of adhesive proteins
and soluble factors were used to reflect changes in the arterial microenvironment. (e) Timeline of experiments. ‘‘Contractile’’
denotes phenotype synching; GM and DM are growth and differentiation mediums, respectively.

where ha is the ratio of the contact radius to the thickness of the hydrogel. However, a direct calculation of
the Young’s modulus requires independently determining the Poisson ratio, v, and thus we report an
effective modulus, E* ¼ 1E-m2 ; in Fig. 1. Conveniently,
fully swollen hydrogels are typically considered to be
incompressible under relevant time scales of loading 2
with Poisson ratios in the range of 0.4–0.5. Therefore,
to facilitate comparisons with other reports, we also
present these mechanical results in Fig. 1 as Young’s
moduli, E, with an assumed Poisson’s ratio of v = 0.5,
and we refer to these values throughout the remainder
of the text.

Protein Functionalization to Hydrogel Surfaces
Two protein cocktails were prepared in PBS (Figs. 1c
and 1d): ‘BaM’ (basement membrane representation)
containing 50% (w/v) collagen IV (recombinant human;
Sigma-Aldrich) and 50% laminin (mouse), and ‘InF’
(inﬂammatory ECM representation) containing 50%
monomeric collagen I (rat tail) and 50% ﬁbronectin
(human plasma; EMD Millipore, Billerica, MA). Glacial acetic acid was added to the InF cocktail at 0.14
vol.% to prevent collagen ﬁbril formation.
Hydrated gels were treated with sulfo-SANPAH
(0.3 mg/mL in pH 8.5 HEPES buﬀer; ProteoChem,
Denver, CO) under UV light for 10 min at ~3 in. They

were then washed with PBS 29 and incubated with
75 lL of cocktail for a 3 lg/cm2 theoretical surface
concentration. After 20 h, gels were transferred to
fresh wells, washed 39 over 30 min in PBS, and UV
sterilized for at least 30 min prior to cell seeding.
Cell Proliferation Assays
SMCs were seeded onto gels (~5600 cells/cm2), and the
initial cell populations were assessed 24 h post-seeding,
then once more after they were synched into the contractile phenotype and stimulated for 96 h with either
SMDS- or SMGS-containing DMEM (‘differentiation
medium’ and ‘growth medium,’ respectively). AlamarBlue was used to quantify relative cell numbers, using
ﬂuorescence (kex = 550 nm, kem = 585 nm) measured
with a Spectramax M5 microplate reader (Molecular
Devices, Sunnyvale, CA). Results are reported as the
fold-difference between the ﬁrst and ﬁnal days, from a
minimum of 5 biological replicates per condition.

100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1%
Triton X-100, 10% glycerol, 0.1% SDS, 0.5% deoxycholate) with freshly added protease inhibitors (cOmplete Mini EDTA-free protease inhibitor tablets;
Roche Applied Sciences, Penzberg, Germany). Sample
protein concentrations were measured with the Pierce
BCA assay (Thermo Fisher) and a BioTek ELx800
absorbance microplate reader (BioTek, Winooski,
VT), normalized, boiled with Laemmli buffer,
separated on 4–20% Tris–glycine polyacrylamide gels
and transferred to PVDF membranes via Western
blotting. SMC markers were detected with primary
antibodies for calponin (clone EP798Y, 1:10000; Abcam, Cambridge, MA) and smoothelin-B (clone H300, 1:200; Santa Cruz Biotechnology, Dallas, TX),
with cyclophilin B as an internal control (1:10,000,
Thermo Fisher). Bands were visualized with HRP
secondary antibodies and enhanced chemiluminescence using a Syngene G:Box.
Characterization of SMC Morphology

Cell Migration and Invasion Assays
For motility assays, cell-seeded hydrogels were immobilized in the wells of 24-well plates with 5-min
epoxy (Devcon, Danvers, MA) following phenotype
synching and treated with either diﬀerentiation or
growth medium. Cell migration was quantiﬁed by
recording x–y positions with a Zeiss Axio Observer Z1
(Carl Zeiss) in brightﬁeld for 12 h at 15 min intervals.
Cell positions were manually tracked with ImageJ using the Manual Tracking plugin, and we calculated the
average velocity, displacement, and chemotactic index
of each tracked cell by ﬁtting to a random walk model
in MATLAB with code provided by Aaron Meyers
(MIT, Whitehead Institute). The results are reported as
the average cell speed and chemotactic index, from a
minimum of 3 independent biological replicates and
100 cells per condition.
For invasion assays, 300 lL 3 mg/mL collagen I
gels (rat tail) were polymerized directly on cell-seeded
gels following phenotype synching, in the presence of
either differentiation or growth medium. Cells were
allowed to invade into the collagen gels for 4 days, and
then imaged with a Zeiss Axio Observer Z1 with 30 lm
Z-slices. The results are reported as the average cell
invasion depth, from a minimum of 3 independent
biological replicates and 140 invaded cells per condition (with the exception of two biological replicates of
the soft BaM condition in differentiation medium).
SMC Marker Western Blotting
SMCs on gels (~11,000 cells/cm2) were lysed using
ice-cold Tris-Triton lysis buffer (10 mM Tris, pH 7.4,

Sparsely seeded SMCs were ﬁxed with 4%
formaldehyde, blocked with 5% bovine serum albumin
(BSA) in Tris-buﬀered saline with 0.1% Triton-X100
(TBS-T), and stained with Cellomics Whole Cell Stain
Blue (Thermo Fisher) for 90 min according to the
manufacturer’s instructions. Imaging was performed
with a Zeiss Axio Observer Z1 at 910 magniﬁcation.
Individual cells were manually traced in ImageJ and
characterized with the built-in ‘‘Measurement’’ tool.
The results are reported here as average cell properties
from at least 3 independent biological replicates and
100 cells per condition.
To visualize focal adhesions and actin stress ﬁbers,
cells were rinsed 29 with warm PBS, ﬁxed in fresh 4%
formaldehyde, and blocked with AbDil (2% BSA in
TBS-T). Vinculin was immunoﬂuorescently labeled
with a monoclonal mouse anti-vinculin antibody
(Sigma-Aldrich) and an anti-mouse FITC secondary
antibody (Jackson ImmunoResearch Laboratories,
West Grove, PA). F-actin was ﬂuorescently labeled
with Alexa Fluor 555-conjugated phalloidin, and cell
nuclei were labeled with DAPI (MP Biomedicals,
Santa Ana, CA). Antibody incubations were performed for 1 h in AbDil, in the dark, and cells were
thoroughly washed between labeling steps with TBS-T.
Each sample was equilibrated with ProLong Gold
antifade reagent for 5 min before imaging. Images
were taken with a 639 oil immersion lens on a Zeiss
Axio Observer Z1 microscope, and ImageJ (NIH,
Bethesda, MD) was used to adjust the brightness and
contrast for clarity in ﬁgures. In separate experiments,
calponin and smoothelin were stained in the same
manner using the antibodies also used for Western

blotting and an Alexa Fluor 444 conjugated secondary
antibody for visualization.
Cell Signaling Time Course with MAGPIX
Multiplexing
A MAGPIX (Luminex Corporation, Austin, TX)
and cell signaling multiplex assay kit (48-680MAG;
Merck Millipore, Billerica, MA) was used to measure
the activities of nine phospho signaling proteins
(CREB, ERK, NFjB, JNK, p38, p70 S6 K, STAT3,
STAT5 and Akt) during 3 separate time courses: (1)
directly during seeding onto biomaterial surfaces, (2)
during TGFb1 treatment after 48 h of serum starvation, and (3) during stimulation with differentiation
medium. Only those signaling molecules that showed
signiﬁcant changes are reported. Lysis was performed
with MAGPIX lysis buffer (50 mM Tris–Cl, pH 7.1,
1% NP-40, 10% glycerol, and 150 mM NaCl) with
freshly-added phosphatase inhibitors (Phosphatase
Inhibitor Cocktail II, 29 working concentration;
Boston BioProducts) and protease inhibitors (cOmplete Mini, EDTA-free), plus (all from Thermo Fisher
Scientiﬁc) additional sodium pyrophosphate (1:100
from 0.1 M stock), b-glycerophosphate (1:40 from 1 M
stock), PMSF (1:500 from 0.5 M stock), leupeptin
(1:1000 from 10 mg/mL stock) and pepstatin A (1:1000
from 5 mg/mL stock). The MAGPIX assays were
performed according to the manufacturer’s instructions. The results are reported here as the average net
mean ﬂuorescence intensity (Net MFI) of 2–4 biological replicates per condition and time point.
Kinase Inhibition Experiments
SMCs (~11,000 cells/cm2) were serum starved for
48 h, then kinase inhibitors were co-administered with
TGFb1 as described above. Akt was inhibited with sc-66
at 1 lg/mL (20 mg/mL stock in DMSO; Abcam) for
1 h, FAK with FAK inhibitor 14 at 100 lM (100 mM
stock in DMSO; Merck Millipore) for the duration of
the experiment, and PI3K with LY294002 at 50 lM
(50 mM stock in DMSO; Merck Millipore) for 1 h.
After 48 h the samples were lysed and Western blotted
for calponin and smoothelin, as described above.
Statistical Analysis
Statistical analysis was performed using Prism v5.04
(GraphPad Software, La Jolla, CA) and the Real Statistics Resource pack software (Release 3.5). Copyright
(2013–2015) Charles Zaiontz. www.real-statistics.com.
Data are reported as mean ± standard error, unless
otherwise noted. Statistical signiﬁcance of mean differences was evaluated with an unpaired Student’s t test, and

two-way ANOVAs with 1 ﬁxed factor were performed
where noted. Two-factor ANOVA (via regression) analysis of collagen invasion depth data (due to the large
number of data points), and three-factor ANOVA (via
regression) analysis of invasion and proliferation data
sets were performed using the Real Statistics Resource
Pack. p £ 0.05 is denoted with *, £0.01 with **, £0.001
with *** and £0.0001 with ****; p > 0.05 was considered
not signiﬁcant (‘ns’).
RESULTS
PEG-PC Hydrogels are Highly Tunable and Capable of
Supporting SMC Diﬀerentiation
We used indentation to quantify the eﬀective modulus of samples that were prepared identically to those
used in biological experiments. As expected for a linear
elastic material loaded with a ﬂat punch geometry, the
relationship between force and displacement is linear
for all compositions and the two crosshead speeds
tested (Figs. 1a–1c, 0.5 lm/s, and Suppl. Fig. 1,
0.1 lm/s). We found that the slopes of these curves
generally increases with crosslinker (PEGDMA) concentration, which indicates an increasing stiffness
possibly due to the formation of a denser network, as
previously described.18 To create a biomaterial environment that captured key biochemical and physical
environments, we coupled the tunable mechanics of the
PEG-PC gel system with ECM proteins representative
of the proteins to which SMCs are attached in a
healthy medial layer (basement membrane, or BaM),
or those representative of an inﬂammatory plaque
(inﬂammatory or InF) (Fig. 1d). These insoluble cues
were combined with soluble factors also commonly
found in these two scenarios. In all ensuing experiments, SMCs were seeded onto gel surfaces with
deﬁned modulus and integrin-binding proteins, serumstarved, and ﬁnally treated with TGFb1 to prime the
cell culture into a differentiated, ‘‘contractile’’ state on
day 5 (Fig. 1e).
Integrin Binding Regulates SMC Proliferative Response
to Soluble Factors
We quantiﬁed the proliferation of initially contractile SMCs on gels from 40 to 94 kPa, after 4 days of
culture in growth or diﬀerentiation medium (Figs. 2a
and 2b) and found that the InF ECM promotes a
higher rate of proliferation in combination with differentiation medium than does the BaM ECM, but in
growth medium the difference in means were not statistically signiﬁcant at each stiffness level. Modulus
generally had a positive effect on proliferation, with
the exception of proliferation on the InF ECM in
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FIGURE 2. Physicochemical effects on SMC growth and motility. (a, b) SMC proliferation at 4 days of culture was measured as a
function of hydrogel modulus (x-axis), on either BaM (blue) or InF (red) proteins, and stimulation with either growth medium (a) or
differentiation medium (b). An asterisk (*) indicates significantly different from softest condition. Black asterisks (*) indicate
significance at that stiffness, blue asterisks (*) indicate significant difference from stiffer BaM conditions. Error bars are 6 SEM
with N = 5–6 independent biological replicates. (c, d) SMC migration speed (c) and chemotactic index (d) was quantified as a
function of Young’s modulus (x-axis) on the different integrin-binding proteins (colors) and stimulated with medium conditions
(solid and dashed lines). Error bars are 6SEM with N > 100 cells and at least 3 independent biological replicates. (e, f) In a collagen
gel invasion assay, SMCs were seeded on two different stiffness gels, and on the two protein combinations (colors). Their invasion
into an overlaid collagen gel was measured in both medium conditions (x-axis). Data is presented as Tukey box plots with N > 100
cells from at least 3 independent biological replicates (with the exception of 2 independent replicates for soft BaM in differentiation
medium.).

differentiation medium. This effect was most pronounced with the combination of the BaM ECM and
differentiation medium (Fig. 2b). Substrate modulus
had a less pronounced effect on proliferation on the
InF conﬁguration with growth medium, and played no
signiﬁcant role with differentiation medium.
Three-factor ANOVA analysis found that medium
type was the single largest driver of proliferation (23%

of total variance, p < 0.0001), followed by modulus
(9%, p < 0.001) and ECM (6%, p < 0.001). Intriguingly, while we did ﬁnd that the interaction between
ECM and medium was signiﬁcant, the effect on total
variance was small (1.8%, p < 0.05). This result is
counter to our initial conclusions from visual inspection of the data, and it is possible that the large contribution of random error to the total variance may be

obfuscating the strength of the interaction between
ECM and medium in the ANOVA analysis.
However, when we considered the data sets for each
ECM composition independently and performed twoway ANOVAs comparing medium and modulus, we
found that medium had a larger eﬀect on total variance
with BaM ECM (30% of total variance from medium,
p < 0.0001) than with InF (19% from medium,
p < 0.0001), which agrees with visual inspection. This
conclusion is further corroborated by the ﬁnding that,
when proliferation in each medium is analyzed independently, ECM is a signiﬁcant factor in differentiation medium, but not growth medium (28.5 vs. 1.5%
of total variance, with p < 0.0001 and p = 0.25 for
differentiation and growth medias, respectively). Taken together, we conclude from these results that soluble
factor sensitivity is dependent on integrin-ECM interactions, in agreement with a previous study comparing
ﬁbronectin, collagen, and laminin-coated gels.38
Heparin is well known to inhibit the effects of certain
growth factors on SMC proliferation8,25 further supporting this hypothesis. However, the soluble factors in
growth medium are apparently capable of overriding
any growth inhibitory effects mediated by the BaM
ECM, resulting in no apparent ECM-speciﬁc differences in proliferation with this condition.
Integrin Binding is the Most Signiﬁcant Driver of
2D and 3D Motility

Both

As models of the early stages of SMC invasion into
a developing plaque, we evaluated both the 2D random migration and 3D invasiveness of SMCs as
modulated by the various physical and chemical factors in our system (Figs. 2c–2f). We found that ECM
and medium type had a very signiﬁcant impact on
average cell speeds and migration directionality
(Figs. 2c and 2d). SMC speed has been reported as
biphasic with respect to substrate modulus,34 which we
did not observe in our initial experiments; however,
after introducing an even softer condition (11 kPa), we
found that cells on BaM in differentiation medium
migrated much slower than the other stiffnesses,
demonstrating that the biphasic regime for BaM and
differentiation medium was not spanned in our original experiments (not shown). Unexpectedly, the average speed on BaM is signiﬁcantly higher than on InF
with either medium supplement, but the chemotactic
index on InF is higher. This latter result indicates that
cells on BaM migrated erratically and non-directionally. Growth medium generally increased both random
migration speed and the chemotactic index on both
ECMs. We quantiﬁed the effects of these 3 factors with
ANOVA analyses: when considering each factor level
independently and applying two-factor ANOVA with

the remaining factors, we found signiﬁcant interactions
between all factor pairs (p < 0.0001), but the effects
were weak (1–12% of total variance from interactions,
average 4.8%). On the whole, ECM was the most
signiﬁcant factor affecting migration speed (88, 53, 76,
and 86% of total variance at each increasing stiffness
level, p < 0.0001 for all), and the medium type had a
greater effect on migration speed on InF ECM than on
BaM (9 vs. 1%, p < 0.0001). The effect of modulus,
however, was modest, never exceeding 4% of total
variance. Very similar trends and effects were found
with the chemotactic index data.
Given these surprising results on 2D surfaces, we
hypothesized that integrin binding was signiﬁcantly
inﬂuencing cell adhesion, and could therefore impact
3D invasion as well. With a collagen gel invasion assay, we found that SMC invasion depth is greater from
the BaM ECM in growth medium, with a modest increase in invasion depth from soft vs. stiﬀ substrates
(Figs. 2e and 2f). Invasion depth in differentiation
medium was overall shallow, but greater for the soft
BaM condition. Given the observed weaker adhesion/
spreading on BaM, it is possible that invasion depth is
greater due to ease of detachment; however, since the
SMCs are given 4 days to invade the collagen matrix,
BaM may also induce phenotypic changes that affect
the SMCs long after leaving the BaM surface. Interestingly, as with migration speed, we found with threefactor ANOVA (via regression) that medium and ECM
signiﬁcantly affected invasion depth, but unlike with
migration speed, the effect of medium was greater (13
vs. 8.5%, p < 0.0001). Similarly, modulus only weakly
affected invasion depth (2% of variance, p < 0.0001).
When we analyzed the growth medium data independently with two-factor ANOVA, the ECM type accounted for 14% of the total variance (p < 0.0001) in
this medium type, and stiffness for <3% (p < 0.0001),
with no signiﬁcant interaction. Taken together, we
conclude that ECM is the major determinant of SMC
2D migration characteristics and a signiﬁcant factor in
collagen invasion, but medium has the greatest impact
on invasive properties.
Since SMC phenotype is reported to be correlated
with cell shape and size,24 we quantiﬁed morphology
on our various surfaces (Figs. 3a and 3b). We found
that cells are approximately two–threefold larger in
area on InF compared to BaM, consistent with a
synthetic phenotype on these inﬂammatory proteins.
Average cell aspect ratio (AR) was used to evaluate the
‘spindle’-like shape of SMCs, with high ARs indicating
an elongated, spindle-like morphology, indicative of
the contractile phenotype. We found that the average
cell AR has little dependence on modulus or ECM
after synching (Suppl. Fig. 2), which is further
validation that this priming step does chemically
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FIGURE 3. SMC adhesion and morphology is affected by ECM. (a, b) Cell spread area (a) and aspect ratio (b) were quantified with
manual tracing as a function of hydrogel modulus (x-axis) on each protein cocktail (colors) and medium condition (dashed and
solid lines). Error bars are 6SEM with N > 100 cells and 3 independent biological replicates. (c) Immunofluorescent staining of
vinculin (green), actin stress fibers (orange), and nuclei (DAPI) of SMCs on two stiffness gels, on each integrin-binding condition,
both in growth medium after 48 h of culture. Scale bar is 50 lm.

‘‘sync’’ the otherwise heterogeneous cells into a consistent, differentiated cell population, even though they
are seeded onto different stiffness gels with different
integrin-binding conditions. Remarkably, we observed
that the average AR of cells on BaM in growth
medium increases with substrate modulus, and it is
higher overall than on InF with either growth or differentiation medium stimulation. Thus, although ARs
are synched during TGFb1 treatment, this contractile
phenotype appears to be better maintained, at least
with respect to cell morphology, on stiff gels with
basement membrane proteins, regardless of the ensuing medium conditions. We have visualized these
morphological differences with immunoﬂuorescent
staining in Fig. 3c.
Stiﬀness and Soluble Factors Modulate Marker
Expression
To connect SMC motility and proliferation
to
prototypical markers of SMC diﬀerentiation, we
evaluated the expression of calponin and smoothelin
via Western blotting (Figs. 4a and 4c). Synthetic
SMCs secrete ECM and are classically characterized
by the downregulation of several marker proteins
(caldesmon, calponin, SM-MHC, smoothelin, and
more45,46,48). These proteins interact with the actin
cytoskeleton and have roles in regulating actomyosin
contractility, and are therefore involved in mechanotransduction. In agreement with previous reports,16
we found that treatment with TG-Fb1 during the

synching steps dramatically increased expression of
both calponin and smoothelin following serum starvation. The differentiation medium supplement
(SMDS) is intended to promote SMC differentiation,
while the growth medium induces proliferation and
dedifferentiation. In agreement with these expectations, we found that, relative to TGFb1 treatment,
calponin expression is modestly up- and downregulated by differentiation and growth medium, respectively (Figs. 4a and 4c). Smoothelin expression,
however, increases slightly with differentiation and
further increases with growth medium (Figs. 4c and
4d). Calponin expression also increases somewhat on
stiff, InF-coated substrates with differentiation medium, but is not affected by stiffness in the other contexts, whereas smoothelin expression is enhanced on
stiff substrates with TGFb1 and differentiation
medium, or with growth medium on InF. While the
effect of stiffness was modest overall, it was most
pronounced in combination with InF, and expression
of both markers was greater on InF than BaM on
soft substrates. In fact, though these expression patterns were consistently observed, we believe it is actually the relative lack of substantial differences in
expression across conditions after synching that is the
most intriguing conclusion derived from these results.
This is in spite of some major differences in cell behaviors (Fig. 2), a ﬁnding that directly contradicts the
notion that SMC marker expression and pathological
behaviors indicative of the synthetic phenotype are
inversely related.

(a)

Calponin

(b)

BaM

Cy. B

InF

SS TGFβ DM GM SS TGFβ DM GM

Cy. B

(e)

(c)

Smoothelin

(d)

InF BaM

SS TGFβ DM GM SS TGFβ DM GM
Cy. B

400
300
200

GAPDH
SMTN

100
bp

Cy. B

40 kPa

94 kPa

FIGURE 4. Expression of calponin and smoothelin has greater dependence on soluble factors than ECM. Representative Western
blots for calponin (a) and smoothelin (c) after each step of priming and stimulation with growth or differentiation medium. SS:
Serum-starve, TGFb: TGFb1 treatment step, DM: switch to differentiation medium, GM: switch to growth medium. Internal control
bands for normalization are cyclophilin B (Cy. B). Immunofluorescent staining of calponin (b) and smoothelin (d) (green) with actin
(red) and DAPI (blue). Scale bar is 50 lm. (e) Reverse transcriptase PCR to confirm expression of SMTN-B mRNA.

Given the reported scarcity of smoothelin in cultured SMCs,45 we visualized actin ﬁbers with calponin
or smoothelin via immunoﬂuorescence (Figs. 4b, 4d).
These results conﬁrmed antibody speciﬁcity for stressﬁber localized proteins and co-localization of
smoothelin to the nucleus.43 Since the robust expression of smoothelin we observed was unexpected, we
conﬁrmed expression of the smoothelin-B mRNA with
reverse transcriptase PCR in SMCs grown on TCPS in
FBS-containing growth medium (Fig. 4e).

FAK Controls SMC Plasticity, in Part Through
PI3K/Akt
To understand the possible signaling mechanisms
driving the phenotypic diversity of the SMCs we had
observed thus far, we quantiﬁed the activation of several major signaling proteins during adhesion, TGFb1
treatment, and stimulation with differentiation medium, using a phospho-protein multiplex assay (Fig. 5).
We observed characteristic spikes in phosphorylation
of ERK and Akt on each modulus tested, and phosphorylation was generally higher on the InF ECM
(Fig. 5a). We observed minimal to no phosphorylation
of Akt during TGFb1 stimulation (not shown), and
ERK again peaked at early time points and was enhanced on the InF surfaces. Interestingly, ERK phosphorylation was greater on the stiffer hydrogel during
TGFb1 stimulation (Fig. 5b). Finally, we saw Akt and
ERK activities diverge during stimulation with differentiation medium (Fig. 5c). Akt appears to be suppressed with differentiation, and recovers after 24 h,
whereas ERK is again stimulated during the medium
change. We see, again, that the phosphorylation of

both these proteins is higher on the InF surface with
minimal modulus-dependent effects.
We then performed experiments with inhibitors to
signaling proteins that are associated both with Akt
and integrin activity to draw a connection between our
observed SMC phenotypes and ECM composition
(Fig. 5d). We found that FAK was the strongest upstream driver of SMC differentiation on all conditions.
In fact, inhibition of FAK completely abrogated expression of both calponin and smoothelin (Fig. 5d).
However, while inhibition of PI3K or Akt reduced
expression of calponin, it had little to no effect on
smoothelin expression. Interestingly, though we did
not ﬁnd any substantial differences in expression between the two protein cocktails, it is of note that cells
on InF remained well-spread and appeared relatively
normal over 48 h, but cells on the BaM ECM undergo
rounding and detachment, prohibiting us from obtaining data for the 40 kPa BaM condition with Akt or
FAK inhibitors. These results imply that regulation of
smoothelin and calponin expression diverges downstream of activated FAK, though PI3K and Akt may
still play a smaller role. We also investigated the impact of ERK and Akt inhibition on proliferation outcomes, but Akt inhibition for 96 h (with inhibitor
reapplied at 48 h) caused total cell loss through detachment and/or apoptosis under all conditions, and
ERK inhibition had inconsistent, statistically insigniﬁcant effects (Suppl. Fig. 3).

DISCUSSION
We designed a 2D biomaterial system that reﬂects
several major, physicochemical changes in the in vivo
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extracellular microenvironment that are purported to
occur during the progression of atherosclerosis and
restenosis. Our observations demonstrate that interplay between the various components of a complex
microenvironment modulate phenotype and behavior
in complicated, unexpected ways. In fact, many assumptions from the SMC literature on/in other in vitro
environments do not hold here, which we suspect is
due to the focus on single physicochemical cues, instead of the combinatorial approach we have taken
here.
One surprising aspect revealed by our data is that expression of SMC marker proteins is not inversely related
to pathological behaviors associated with the synthetic
phenotype (i.e., proliferation and motility) as commonly
reported.5,6,9,13,39 In fact, expression of calponin, and
smoothelin to a lesser extent, were higher in SMCs on soft
substrates with inﬂammatory rather than basement
membrane proteins. In contrast, proliferation was signiﬁcantly greater on InF than BaM in differentiation
medium, whereas motility was signiﬁcantly greater on
BaM. While this latter observation does hint at an inverse
relationship between marker expression and migration
speed, expression is only higher with InF on the soft
condition. This suggests that the relationship between
marker expression and pathological behaviors is variable
and inconsistent, and that the signaling pathways
regulating SMC proliferation and motility are not strictly
antagonistic to those regulating marker expression, or
possibly even coupled at all. However, the proliferation
trends in differentiation medium indicate that the effects
of soluble factors in these contexts are modulated by integrin activity.19,21
In agreement with expected eﬀects of these ECM
proteins on SMC phenotype, we found that both medias induced a contractile, spindle-shaped morphology
on BaM and a large, rhomboidal shape associated with
the synthetic phenotype on InF (Fig. 3 and Suppl.
Fig. 2). Remarkably, these traits did not correspond to
substantial differences in expression of calponin or
smoothelin, despite their purported status as components of the SMC contractile apparatus. Of equal interest is the observation that migration and invasion
characteristics are disconnected from SMC marker
expression. However, upon further reﬂection, the in-

vasion from the BaM ECM towards growth medium
models the process of detachment from the basement
membrane and migration towards chemoattractants in
a developing plaque (Figs. 2e and 2f). Therefore, we
speculate that SMCs in this model may be reﬂective of
an invasive phenotype characteristic of the early stages
of atherosclerosis. Finally, our initial experiments
showed that the effect of stiffness on 2D migration
speed did not follow the previously reported biphasic
trend in vitro.34 We initially explained this by our
multiple ECM protein approach, as this previous study
was done on pure ﬁbronectin, and collagen IV has
been previously reported to strongly enhance SMC
motility relative to the other ECM proteins used
here.31 We investigated this further by performing
additional migration experiments with BaM on 11 kPa
PEG-PC in differentiation medium, and possibly
identiﬁed the range of elastic moduli over which SMCs
migrate biphasically in this microenvironment.
Measurement of several signaling protein activity
levels over time implicates Akt and ERK1/2 signaling
pathways in regulating these phenomena, the activities
of which are overall greater on InF than BaM (Fig. 5).
Increased stiffness also enhanced signaling under certain conditions, but relatively modestly. This analysis
was followed up with kinase inhibition experiments to
identify potential connections between cell signaling
pathways and integrins/focal adhesion complexes. The
effects of Akt and FAK inhibitors were similar on soft
BaM during TGFb1 treatment, with total loss of cells
by 48 h, but PI3K inhibition only caused signiﬁcant
rounding. Cell rounding was also dramatic with all
inhibitors on stiffer BaM, but cells were not completely
detached. Remarkably, inhibitors had little visible effect with InF during TGFb1 treatment, with the interesting exception that FAK inhibition dramatically
reduced cell–cell contacts (not shown).
We also measured the eﬀect of kinase inhibition
during TGFb1 treatment on marker expression and,
despite apparently signiﬁcant effects on the actin cytoskeleton and/or adhesion structures, were surprised
to ﬁnd little relation between markers and attachment/
rounding. The most intriguing ﬁnding is that FAK
inhibition completely abrogates expression of both
markers, implicating FAK as a key regulator of contractile marker expression in 2D. Furthermore, expression of calponin and smoothelin appear to be
regulated by distinct, but possibly overlapping signaling pathways that diverge downstream of FAK. This
conclusion is derived from the ﬁnding that smoothelin
is modestly affected by PI3K inhibition, but barely
affected by Akt inhibition, whereas calponin is
strongly downregulated by inhibition of either on
BaM. On InF, however, calponin is more strongly
regulated via Akt than PI3K, which further indicates

that Akt may be activated through ILK instead of
PI3K.
The likely explanation of how integrin binding in
our system regulated stiﬀness and medium condition sensitivity is crosstalk between integrin binding
and colocalized growth factors. Numerous studies (for
review, see Ref. 37) have reported a concomitant increase in migration and proliferation after treatment
with soluble factors or mechanical stimulation, and
our data agrees with this notion. However, it has long
been hypothesized that migration and proliferation of
synthetic SMCs in atherosclerosis are temporally distinct phenomena.7,26 We believe this seeming contradiction between in vitro data and physiological
intuition is an illustrative example of the limitations
necessarily imposed by simpler models. Our data
indicates that, as the ECM surrounding SMCs changes
from a basement membrane composition to that found
in a plaque, there is a switch from migratory behavior
to a high rate of proliferation. This data altogether is
in vitro evidence that proliferation and migration may
be inversely related with respect to particular ECM
compositions, a conclusion that ﬁts well with our understanding of the pathology of atherosclerosis.
From our data and previous work, we propose a
hypothetical signaling pathway diagram in Fig. 6 that
may explain the impact of ECM composition on SMC
phenotype and behaviors, and how these processes are
modulated by soluble factors. As described above, our
inhibitor experiments indicate that FAK regulates the
expression of SMC markers, and suggest that calponin
and smoothelin regulation may diverge downstream of
FAK. These experiments also indicate that calponin
expression may be mediated primarily via PI3K/Akt on
BaM and ILK/Akt on InF, whereas smoothelin may be
regulated via disparate, or possibly partially overlapping
pathways. We additionally propose that activation of
different integrin heterodimers—most likely aVb3 on
InF and a2b1 on BaM—well explains the physiologically
relevant phenomena we observed. The much greater
spreading area and slower migration of SMCs on InF, as
well as a higher prevalence of stress ﬁbers and vinculinrich focal adhesions, is an indicator of signiﬁcant FAK
autophosphorylation,36 which in turn may recruit and
activate c-Src and enhance overall FAK signaling.30 In
fact, b3 integrin itself provides Src homology 2 (SH2)
binding domains for direct association of c-Src independent of actin and focal adhesion assembly. 3 The
higher prevalence of these signaling motifs on InF may
lead to greater proliferation by accumulated signaling
through the c-Src/ERK1/2 and/or FAK/ILK/Akt
pathways, and greater spreading through FAK-mediated enhancement of RhoA/ROCK and stress ﬁber
formation. In contrast, while a2b1 integrin activation on
BaM is likely to generate many of the same signaling

FIGURE 6. Proposed mechanisms and signaling behindc
ECM-dependent behaviors. (a) Integrin ligation on InF, in
particular aVb3, promotes strong adhesion and spreading,
FAK autophosphorylation, focal adhesion formation, FAK/ILK/
Akt signalling to induce marker expression and/or proliferation, or c-Src localization and ERK1/2 signaling. Association of growth factor receptors (GFRs) with integrins may
enhance proliferative signaling via c-Src. (b) On BaM, a2b1
integrin is likely a key mediator of ECM-specific signaling. The
prevalence of active FAK is overall lower, resulting in weaker
adhesion, poor spreading, and rapid FA turnover, promoting
migration.

patterns,19 the weaker adhesion we observed suggests
lower FAK/c-Src signaling, resulting in dampened
proliferation.
We also propose a mechanism that explains our
observed ECM-controlled switch from a migratory to
a proliferative phenotype. Prior work with ﬁbroblasts
revealed that these cells are motile and proliferative at
low and high concentrations of PDGF, respectively, a
switchover mediated by clathrin-mediated endocytosis
(CME) and raft/caveolin-mediated
endocytosis
(RME).10 We hypothesize that this switching of endocytic mechanisms could also be induced by changes
in integrin activation. This proposal ﬁts well with the
ﬁnding that migration is random and non-directional
on BaM, as CME is responsible for rapid, localized
recycling of growth factor receptors at the plasma
membrane, which enables a fast cellular response to
transient microgradients of chemoattractants.11 The
adhesion properties on BaM also suggest faster turnover of FAs, which is likely to support rapid migration
on soft substrates. This latter mechanism would seem
to also apply to a2b1 integrin binding to monomeric
collagen I on InF, but this is likely mitigated by the
additional presence of ﬁbronectin, which has been
found to dramatically increase phosphorylation of
paxillin,4 decrease migration, and increase spreading.1
Soluble factors play a role in these phenomena by
activating integrin-associated growth factor receptors,
which further enhance mitogenic signaling via c-Src
and/or Akt. Despite the relative scarcity of soluble
factors in differentiation medium, proliferation is
greater on InF due possibly to overall greater basal
activation of mitogenic signaling induced by ligandfree association of integrins and GFRs. Other possible
contributory factors include the induction of autocrine
growth factor production by heparin41 or collagen I,23
supported by our ﬁnding that Akt activity increased
after 24 h in differentiation medium on the stiff condition. Proliferation is lower on BaM, however, due to
a lack of many of these effects and/or potential sequestration of TGFb1 in the pericellular matrix by
collagen IV,27 which has been shown to potentiate the
growth factor inhibition of heparin.29 Finally, despite
the lack of signiﬁcance between the fold-change in cell
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populations, we propose that SMCs on InF in growth
medium actually proliferate more than on BaM due to
the mechanisms described above, but this is obfuscated
by the greater spreading and attachment of SMCs,
resulting in faster saturation of the surface and cell–cell
contact inhibition.

CONCLUSIONS
We present here a simple in vitro biomaterial system
that can parse out the complexity of SMC phenotype
and signalling while under multi-factorial exposure to
differences in substrate modulus, integrin binding, and
soluble factor stimulation. The novelty in our approach was initially synching cell populations on different surfaces, and then probing their susceptibility to
the synthetic phenotype when dosed with different
cocktails of soluble factors. This simple change from
previous methods allowed us to see the true phenotypic
diversity of SMCs and helped resolve some contradictions that exist between in vitro and in vivo studies.
Coupled with our signalling analysis, we demonstrated
that integrin binding is the overriding driver of SMC
phenotype, and it dictated SMC sensitivity to soluble
factors. This was modulated primarily by FAK phosphorylation, and we propose FAK’s downstream targets are regulated by the speciﬁc activated integrin
heterodimer and its ability to recruit growth factor
receptors and Src into the focal adhesion complex. In
sum, our results demonstrate the need to examine any
biophysical cue in proper context, and studies of
mechanosensing in isolation (including our own) may
result in incomplete conclusions.
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